
Sign up to save your podcasts
Or


2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
Follow us on LinkedIn, X, Facebook and Instagram.
Visit us at https://www.bio.org/
By Biotechnology Innovation Organization4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
Follow us on LinkedIn, X, Facebook and Instagram.
Visit us at https://www.bio.org/

2,057 Listeners

772 Listeners

755 Listeners

600 Listeners

824 Listeners

310 Listeners

112,217 Listeners

507 Listeners

398 Listeners

125 Listeners

338 Listeners

114 Listeners

149 Listeners

279 Listeners

262 Listeners